Economic Effects of US Tariffs on Germany’s Diagnostics
Key Points Background The US has implemented tariff policies under President Donald Trump, aiming to protect domestic industries by imposing duties up to 25% on various imports, including medical diagnostic equipment from Germany, effective from April 2025. These measures target countries with significant trade deficits, impacting Germany’s export-driven diagnostic sector, which relies heavily on the US market. Impact on German Companies Major German firms like Siemens Healthineers and Carl Zeiss are affected. Siemens, with a global manufacturing strategy, expects minor impacts, while Carl Zeiss Meditec may see gross margins shrink by up to 2 percentage points due to 23% of its business relying on US imports. Roche Diagnostics‘ specific impacts are less clear, but the industry faces increased costs and potential market share losses. Economic and Trade Implications In 2022, Germany exported $17.6 billion in medical instruments, with $3.37 billion…
